Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gonadotoxic Treatment
43%
Oncofertility
41%
Ovarian Tissue
41%
High Risk
38%
Fertility Preservation
32%
Anti-Müllerian Hormone
30%
Hormone Levels
28%
Gonadal Impairment
25%
Childhood Cancer Patients
24%
Infertility
23%
Twinning Project
20%
Genetic Variation
20%
Cytochrome P450 (CYP450)
20%
European Cohort
20%
Candidate Gene Approach
20%
Europe 2020
20%
Fertility Data
20%
Infiltrative Diseases
20%
Pediatric Cancer
20%
Oophorectomy
20%
Dutch
20%
Anesthetic Risk
20%
Tissue Harvest
20%
Surgical Risk
20%
Laparoscopic Surgery
20%
Abdominal
20%
Ovarian Reserve
20%
Genome-wide Association Study
20%
Inter-individual Variation
20%
Meta-analysis
19%
Oocyte Cryopreservation
17%
Alkylating Agents
17%
Low Risk
16%
Gonadal Damage
14%
Late Effects
14%
Risk Factors
12%
Genetic Variants
12%
Adult Female
12%
Fertility Specialist
12%
Cyclophosphamide Equivalent Dose
11%
Ovarian Function
11%
Cancer Treatment
10%
Childhood Cancer Treatment
10%
Comorbidity
10%
Embase
10%
PubMed
10%
Resuscitation
10%
Laparoscopy
10%
Single nucleotide Polymorphism
10%
Statistical Significance
10%
Medicine and Dentistry
Childhood Cancer
100%
Fertility Preservation
69%
Systematic Review
61%
Malignant Neoplasm
57%
fertility
56%
Oncofertility
50%
Hormone Determination
27%
Cancer Therapy
23%
Ovariectomy
23%
Twin Pregnancy
20%
Infiltrative Disease
20%
Genetic Variation
20%
Pediatric Cancer
20%
Laparoscopic Surgery
20%
Genome Wide Association Study
20%
Ovarian Reserve
20%
Ovarian Tissue Cryopreservation
19%
Late Effect
17%
Counseling
17%
Meta-Analysis
15%
Pediatric Oncologist
12%
Genetics
11%
Alkylating Antineoplastic Agent
11%
Cyclophosphamide
11%
Equivalent Dose
11%
Ovary Function
11%
Cryopreservation
10%
Oocyte
10%
Micrometastasis
10%
Maturation
10%
Cancer Treatment
10%
Ex Vivo
10%
Gonad Function
10%
Central Nervous System
10%
Enzymes
7%
CYP3A4
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Solid Malignant Neoplasm
6%
Cancer
6%
Immunophenotyping
6%
Autotransplantation
6%
Ovarian Cancer
6%
Hematologic Malignancy
6%
Leukemia
6%
Ewing Sarcoma
6%
Minimal Residual Disease
6%
Flow Cytometry
6%
Acute Myelogenous Leukemia
6%
Acute Lymphocytic Leukemia
6%
Tumor
6%
